Predictive power of tertiary lymphoid structure signature for neoadjuvant chemotherapy response and immunotherapy benefit in HER2‐negative breast cancer

Authors:

Abstract
No abstract available
Funding Information
  • La Ligue Nationale Contre le Cancer (EL2022: FB)

This publication has 10 references indexed in Scilit: